The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a exciting breakthrough. Unlike subcutaneous injections, this technique offers a less invasive way to provide https://philipfnml851345.theideasblog.com/41448729/glp-1-patches-a-novel-approach-to-blood-sugar-treatment